Detalles de la búsqueda
1.
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
Circulation
; 143(22): 2143-2154, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820424
2.
Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
J Vasc Interv Radiol
; 31(6): 978-985, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414572
3.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet
; 392(10157): 1530-1540, 2018 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266412
4.
One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).
J Vasc Surg
; 63(2): 370-6.e1, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26483003
5.
5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique.
J Am Coll Cardiol
; 82(3): 183-195, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207924
6.
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
Cardiovasc Revasc Med
; 18(7): 475-481, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28923692
7.
Carotid artery in-stent restenosis after carotid artery stenting.
J Invasive Cardiol
; 20(6): 286-91, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18523322
Resultados
1 -
7
de 7
1
Próxima >
>>